BCSE Pharmacology

CNS Drugs in Veterinary Pharmacology – BCSE Study Guide

Central Nervous System (CNS) drugs represent a cornerstone of veterinary practice, spanning sedation, anesthesia, analgesia, seizure management, and behavioral therapy.

Overview and Clinical Importance

Central Nervous System (CNS) drugs represent a cornerstone of veterinary practice, spanning sedation, anesthesia, analgesia, seizure management, and behavioral therapy. These medications act on specific neurotransmitter systems to produce dose-dependent effects ranging from mild anxiolysis to complete unconsciousness. Understanding their mechanisms, species differences, and clinical applications is essential for the BCSE and daily veterinary practice.

This domain tests your ability to select appropriate drugs based on patient status, recognize adverse effects, understand drug interactions, and apply pharmacokinetic principles across species. CNS pharmacology questions frequently appear as clinical vignettes requiring integration of multiple concepts.

High-YieldCNS drugs comprise a significant portion of Domain 2 questions. Master the receptor mechanisms, species differences in metabolism, and reversal agents for exam success.
Property Details
Mechanism Dopamine D2 antagonist; also blocks alpha-1, muscarinic, and histamine receptors
Primary Effects Tranquilization without analgesia; antiemetic; reduces anesthetic requirements by 20-30%
Cardiovascular Hypotension due to alpha-1 blockade and vasodilation; use with caution in hypovolemic patients
Duration 4-6 hours in dogs; half-life approximately 2.5 hours in horses
Dogs 0.01-0.05 mg/kg IV, IM, SQ; commonly used preanesthetic
Cats 0.01-0.05 mg/kg; similar effects to dogs
Horses 0.02-0.1 mg/kg IV; CAUTION: penile prolapse (paraphimosis) risk in stallions/geldings
Contraindications Hypovolemia, shock, severe cardiac disease, breeding stallions (penile prolapse)
Key Clinical Pearl No reversal agent available; effects must wear off naturally
Drug Alpha-2:Alpha-1 Ratio Species Key Features Reversal
Xylazine 160:1 Horses, cattle, small animals Emetic in dogs/cats; vomiting common; used widely in horses/cattle Yohimbine, Atipamezole
Medetomidine 1620:1 Dogs, cats Racemic mixture; more selective than xylazine; available in combination with ketamine Atipamezole
Dexmedetomidine 1620:1 Dogs, cats Active enantiomer of medetomidine; twice as potent; OTM gel (Sileo) for noise aversion Atipamezole
Detomidine 260:1 Horses primarily Prolonged sedation and analgesia in horses; OTM gel available Atipamezole
Romifidine 340:1 Horses Less ataxia than xylazine; longer duration; good for standing sedation Atipamezole

Section 1: Sedatives and Tranquilizers

Sedatives and tranquilizers reduce anxiety and produce dose-dependent CNS depression. The key distinction: tranquilizers decrease anxiety without drowsiness, while sedatives produce drowsiness and hypnosis. Increased doses of tranquilizers cause side effects without loss of consciousness, whereas increased sedative doses can produce anesthesia-like states.

You've been studying hard

Create a free account to keep reading

Free accounts get 5 articles/day + daily practice question

Join 14,000+ vet students already studying with NavleExam.

No credit card needed — free account takes 30 seconds.

Create Free Account — Keep Reading Already have an account? Log in
or skip signup — just get daily questions

No spam. One question per day. Unsubscribe anytime.

BCSE Exam Prep Platform

Everything you need to pass the BCSE

10,000+ Practice Questions
Exam-style with full explanations
Past Exam Papers
Real previous exam questions
Flashcard Mode
Species & topic quick review
High-Yield Study Guides
What's actually on the exam
Start Free Trial → See Plans & Pricing No credit card required to start